We have shown that the canonical IKK–NF-κB/RELA pathway is often aberrantly activated and promotes resistance to effects of TNFα, as well as immune-mediated and radiation cytotoxicity, in head and neck squamous cell carcinomas (HNSCC; refs. 4–6). Here, NFKB1 is linked to head and neck squamous cell carcinoma.